Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 51, Issue 7, Pages 906-912
Publisher
Springer Nature
Online
2016-05-16
DOI
10.1038/bmt.2016.130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
- (2016) P. G. Richardson et al. BLOOD
- Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation
- (2015) Ayman Akil et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes
- (2015) K Yakushijin et al. BONE MARROW TRANSPLANTATION
- Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
- (2015) M Mohty et al. BONE MARROW TRANSPLANTATION
- Modern approaches to HLA-haploidentical blood or marrow transplantation
- (2015) Christopher G. Kanakry et al. Nature Reviews Clinical Oncology
- Continuous Reduced Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Institution’s Three Decade Experience
- (2014) Florent Malard et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How I treat sinusoidal obstruction syndrome
- (2014) N. Chao BLOOD
- MTHFR C677T/A1298C genotype: a possible risk factor for liver sinusoidal obstruction syndrome
- (2014) E Efrati et al. BONE MARROW TRANSPLANTATION
- Allogeneic hematopoietic SCT for adults AML using i.v. BU in the conditioning regimen: outcomes and risk factors for the occurrence of hepatic sinusoidal obstructive syndrome
- (2014) A Nagler et al. BONE MARROW TRANSPLANTATION
- Incidence and risk factors for moderate-to-severe veno-occlusive disease of the liver after allogeneic stem cell transplantation using a reduced intensity conditioning regimen
- (2014) P D Tsirigotis et al. BONE MARROW TRANSPLANTATION
- How I manage sinusoidal obstruction syndrome after haematopoietic cell transplantation
- (2014) Enric Carreras BRITISH JOURNAL OF HAEMATOLOGY
- Hepatic Sinusoidal Obstruction Syndrome Caused by Herbal Medicine: CT and MRI Features
- (2014) Hua Zhou et al. KOREAN JOURNAL OF RADIOLOGY
- Distinct Deleterious Effects of Cyclosporine and Tacrolimus and Combined Tacrolimus–Sirolimus on Endothelial Cells: Protective Effect of Defibrotide
- (2013) Alba Carmona et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation
- (2013) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia
- (2013) Hagop Kantarjian et al. CANCER
- Organ-specific management and supportive care in chronic graft-versus-host disease
- (2012) Fiona L. Dignan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
- (2012) Selim Corbacioglu et al. LANCET
- The Incidence of Veno-Occlusive Disease Following Allogeneic Hematopoietic Stem Cell Transplantation Has Diminished and the Outcome Improved over the Last Decade
- (2011) Enric Carreras et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The role of the endothelium in the short-term complications of hematopoietic SCT
- (2011) E Carreras et al. BONE MARROW TRANSPLANTATION
- Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases
- (2011) Na-Young Shin et al. EUROPEAN RADIOLOGY
- Radiologic Imaging and Intervention for Gastrointestinal and Hepatic Complications of Hematopoietic Stem Cell Transplantation
- (2011) Shmuel Y. Mahgerefteh et al. RADIOLOGY
- Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial Injury
- (2010) Corey Cutler et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Defibrotide for the Treatment of Severe Hepatic Veno-Occlusive Disease and Multiorgan Failure after Stem Cell Transplantation: A Multicenter, Randomized, Dose-Finding Trial
- (2010) Paul G. Richardson et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Linearity and Stability of Intravenous Busulfan Pharmacokinetics and the Role of Glutathione in Busulfan Elimination
- (2010) Shlomo Almog et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and Outcome
- (2009) Jason A. Coppell et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation
- (2009) S. C. Maradei et al. BLOOD
- Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation
- (2008) C. Cutler et al. BLOOD
- Sinusoidal Obstructive Syndrome Diagnosed With Superparamagnetic Iron Oxide–Enhanced Magnetic Resonance Imaging in Patients With Chemotherapy-Treated Colorectal Liver Metastases
- (2008) Janice Ward et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started